Diabetes Care · 2017 · 19 citations · 28 references
MedicineInternal MedicineAgingDiabetologyGeriatricsDiabetes ManagementDiabetes MellitusDiabetic NeuropathyDiabetic RetinopathyLife ExpectancyLongevityClinical Care QualityDiabetes DurationDiabetic Neuropathy AssessmentDiabetic Retinopathy PrevalenceMultivariable AdjustmentMultivariable Regression AnalysisNeuropathy Screening InstrumentsOphthalmic Clinical Examination
OBJECTIVE To assess national differences in diabetes care and quality of life (QOL) between individuals with long-standing type 1 diabetes (≥50 years) in Canada and the U.S. RESEARCH DESIGN AND METHODS Cross-sectional data from identical surveys administered in the Canadian Study of Longevity in Diabetes and the Joslin Medalist Study, collected in 2013–2016 and 2005–2011, respectively, were compared. Laboratory values and ophthalmic examination were completed by clinical care physicians for Canadians and the Joslin Clinic for Americans. Univariate comparisons and multivariable regression for HbA1c, QOL, insulin pump use, and coronary artery disease (CAD) were performed. Nephropathy, CAD, and peripheral arterial disease (PAD) were self-reported; neuropathy was defined by a Michigan Neuropathy Screening Instrument (Questionnaire component) score ≥3, and proliferative retinopathy was documented from ophthalmic examination. QOL was self-reported on an ordinal scale. RESULTS Three hundred sixty-one Canadians and 668 Americans had similar ages (mean 65.78 years [SD 8.67] vs. 66.38 years [7.66], P = 0.27) and durations of diabetes (median 53.00 years [interquartile range 51.00, 58.00] vs. 53.00 years [51.00, 57.00], P = 0.51). Canadians had higher HbA1c (mean 7.53% [SD 1.03] [59 mmol/mol] vs. 7.22% [0.98] [55 mmol/mol], P < 0.0001), lower QOL (36.9% vs. 48.7% with “excellent” QOL, P = 0.0002), and less CAD (29.7% vs. 41.2%, P = 0.0003) and insulin pump use (43.3% vs. 55.6%, P = 0.0002). Other complication rates were similar. Residual differences for Canadians compared with Americans remained after adjustment for age, sex, CAD, PAD, education, and relevant a priori selected variables: 0.28% higher HbA1c (P = 0.0004); and odds ratios of 0.68 (95% CI 0.51, 0.90), 0.46 (0.31, 0.68), and 0.71 (0.52, 0.96) for higher QOL, CAD, and insulin pump use, respectively. CONCLUSIONS Although Canadians and Americans have similar rates of complications other than CAD, further research is required to understand why Canadians have higher HbA1c levels, lower QOL, and less insulin pump use.
28
Jessica M. Sontrop, Stephanie N. Dixon, Amit X. Garg et al. · American Journal of Nephrology · 2013 · 5.9K citations · Full text
Standards of Medical Care in Diabetes—2011
Diabetes Care · 2010 · 2.9K citations · Full text
Marilyn A. Winkleby, Darius E. Jatulis, Erica Frank et al. · American Journal of Public Health · 1992 · 2.1K citations
Public Health, Chronic Disease Prevention, Population Health Sciences +17
Yuji Okura, Lynn H. Urban, Douglas W. Mahoney et al. · Journal of Clinical Epidemiology · 2004 · 1.2K citations